These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3010984)

  • 1. Effects of acidotropic compounds on the secretory pathway: inhibition of secretion and processing of the third and fourth components of complement.
    Hortin G; Strauss AW
    Biochem Biophys Res Commun; 1986 Apr; 136(2):603-9. PubMed ID: 3010984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium depletion blocks proteolytic cleavages of plasma protein precursors which occur at the Golgi and/or trans-Golgi network. Possible involvement of Ca(2+)-dependent Golgi endoproteases.
    Oda K
    J Biol Chem; 1992 Aug; 267(24):17465-71. PubMed ID: 1324939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement biosynthesis by the human hepatoma-derived cell line HepG2.
    Morris KM; Aden DP; Knowles BB; Colten HR
    J Clin Invest; 1982 Oct; 70(4):906-13. PubMed ID: 6288774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational processing of the murine third component of complement.
    Bednarczyk JL; Capra JD
    Scand J Immunol; 1988 Jan; 27(1):83-95. PubMed ID: 3340822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and fragmentation of the third (C3) and the fourth (C4) components of complement: generation and isolation of physiologically relevant fragments C3c and C4c.
    Janatova J; Gobel RJ
    J Immunol Methods; 1985 Dec; 85(1):17-26. PubMed ID: 4078308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and structural characterization of two incompletely processed forms of the fourth component of human complement.
    Chan AC; Atkinson JP
    J Clin Invest; 1983 Nov; 72(5):1639-49. PubMed ID: 6313766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoblotting analysis of plasma protein processing in the secretory pathway of rat liver: identification of proteolytic conversion sites of complement pro-C3 and prohaptoglobin.
    Oda K; Miki K; Hirose S; Takami N; Misumi Y; Ikehara Y
    J Biochem; 1986 Dec; 100(6):1669-75. PubMed ID: 3553170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The third (C3) and fourth (C4) components of complement in human liver. Immunocytochemical evidence for hepatocytes as the site of synthesis.
    Nagura H; Hasegawa H; Yoshimura S; Watanabe K
    Acta Pathol Jpn; 1985 Jan; 35(1):71-8. PubMed ID: 4003098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and partial characterization of the secreted form of the fourth component of human complement: evidence that it is different from major plasma form.
    Chan AC; Mitchell KR; Munns TW; Karp DR; Atkinson JP
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):268-72. PubMed ID: 6572001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The third (C3) and the fourth (C4) components of complement: labile binding site and covalent bond formation.
    Janatova J
    Ann N Y Acad Sci; 1983; 421():218-34. PubMed ID: 6586100
    [No Abstract]   [Full Text] [Related]  

  • 11. Brefeldin A arrests the intracellular transport of a precursor of complement C3 before its conversion site in rat hepatocytes.
    Oda K; Hirose S; Takami N; Misumi Y; Takatsuki A; Ikehara Y
    FEBS Lett; 1987 Apr; 214(1):135-8. PubMed ID: 3569512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of the third and fourth component of complement (C3, C4) by smooth muscle cells.
    Ueda Y; Nagasawa K; Tsukamoto H; Horiuchi T; Nishizaka H; Ikeda K; Niho Y
    Immunology; 1996 Oct; 89(2):183-8. PubMed ID: 8943712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of disulphide bonds and localization of interchain linkages in the third (C3) and the fourth (C4) components of human complement.
    Janatova J
    Biochem J; 1986 Feb; 233(3):819-25. PubMed ID: 3707529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.
    Zimmer B; Hartung HP; Scharfenberger G; Bitter-Suermann D; Hadding U
    Eur J Immunol; 1982 May; 12(5):426-30. PubMed ID: 7094993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentration of complement C3 and C4 in sera containing monoclonal IgA or IgG].
    Bartelik S
    Przegl Lek; 1990; 47(2):265-7. PubMed ID: 2356335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of serum complement (C3 and C4) levels in normal human pregnancy: effect of the development of pregnancy-associated hypertension.
    Gallery ED; Raftos J; Gyory AZ; Wells JV
    Aust N Z J Med; 1981 Jun; 11(3):243-5. PubMed ID: 6945834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of immunoglobulin and complement components C4 and C3 bound to guinea pig tumor cells.
    Segerling M; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Jul; 57(1):145-50. PubMed ID: 187759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
    Ward M; Eastwood MA
    Digestion; 1975; 13(1-2):100-3. PubMed ID: 1201816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement proteins C2, C4 and factor B. Effect of glycosylation on their secretion and catabolism.
    Matthews WJ; Goldberger G; Marino JT; Einstein LP; Gash DJ; Colten HR
    Biochem J; 1982 Jun; 204(3):839-46. PubMed ID: 6922701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
    Andersson M; Hanson A; Englund G; Dahlbäck B
    Eur J Clin Pharmacol; 1991; 40(3):261-5. PubMed ID: 2060562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.